Montpellier, France

Joelle Arnaud

This inventor holds 1 USPTO granted patent. Top assignee: Elf Sanofi, a French Corp.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joelle Arnaud. Retrieved from https://idiyas.com/inventor/joelle-arnaud-pjiflsxm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joelle Arnaud: Innovator in Cardiovascular Treatment

Introduction

Joelle Arnaud is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular disorders. Her innovative work has led to the development of valuable compounds that can potentially improve patient outcomes.

Latest Patents

Joelle Arnaud holds 1 patent for her invention titled "N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders." This patent describes non-peptide compounds that oppose the action of angiotensin II, making them useful in treating conditions such as hypertension and heart failure. The processes for their preparation and the pharmaceutical compositions containing these compounds are also detailed in her patent.

Career Highlights

Throughout her career, Joelle has worked with Elf Sanofi, a leading French corporation in the pharmaceutical industry. Her role at the company has allowed her to focus on research and development, contributing to advancements in medical treatments.

Collaborations

Joelle has collaborated with notable colleagues, including Jean-Louis Assens and Claude Bernhart. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Joelle Arnaud's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to cardiovascular treatment through her patented compounds highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…